Do you have the same question? Follow this Question
Oct 01, 2025 - 04:57 AM
We’ve provided several answers to questions related to Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) , see some other helpful Q&A related to this product.
Question: What are the directions for taking this product?
Answer: It should be taken at the same time each day and swallowed whole, not crushed or chewed. Following these directions ensures the medication's extended-release properties are maintained, providing consistent therapeutic effects.
Question: What are the brand names associated with this product?
Answer: The brand names include Amrix, Fexmid, and Flexeril. Knowing the different brand names can assist in recognizing the product across various formulations and market offerings.
Question: What is the ChEBI identifier for this product?
Answer: The ChEBI identifier is CHEBI:4006. ChEBI (Chemical Entities of Biological Interest) identifiers are useful for understanding the biological role and chemical properties of the compound in scientific studies.
Question: What should be considered during pregnancy when taking this product?
Answer: Use with caution during pregnancy. Caution is advised to avoid potential risks to the developing fetus, ensuring the safety of both the mother and child.
Question: What is the elimination half-life of the immediate-release version of this product?
Answer: The elimination half-life of the immediate-release version is 18 hours. A longer half-life can mean less frequent dosing and sustained relief from symptoms.
View all Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) Questions & Answers
